期刊文献+

2000年湖北省临床细菌耐药性监测报告 被引量:6

Surveillance of CHnical Bacterial Resistance in Hubd Province in 2000
下载PDF
导出
摘要 目的 探讨2000年湖北省临床分离菌对抗菌药物的耐药状况。方法 将湖北地区15所医院纸片扩散法药敏试验的抑菌环直径输入计算机。根据1999年美国临床实验室标准委员会颁布的准则,采用“WHONET-5”软件完成统计分析。结果 临床10 241株分离菌中,最常见的菌种依次为凝固酶阴性葡萄球菌、大肠埃希菌、铜绿假单胞菌、金黄色葡萄球菌、克雷伯菌属、肠球菌属、肠杆菌属,不动杆菌属等。22.0%的金黄色葡萄球菌和69.9%的凝固酶阴性葡萄球菌对苯唑西林耐药,对其他药物的耐药率也高。肠球菌中万古霉素耐药株分别占粪肠球菌和屎肠球菌的3.1%和1.9%。亚胺培南、头孢他啶、阿米卡星、环丙沙星、哌拉西林、头孢噻肟对革兰阴性菌(包括肠杆菌科及非发酵菌)有良好抗菌活性,但与1996年、1999年监测资料比较,敏感率逐年下降。结论 临床细菌耐药性日益严重,应在不同地区开展耐药性监测工作,强调临床合理应用抗菌药物。 Objective To report the surveillance data on bacterial resistance in Hubei hospitals.Methods The diameters of the inhibition zone of clinical bacterial around antibiotic susceptibility test discs in IS Hubei province hospitals were computerfiled and analysed by the software of 'WHONET- 5' according to NCCLS published in 1999.Results A total of 10241 clinical isolates were collected from January 1 to December 31, 2000. Coagulase negative staphylococci (CNS), E.Coli, P.aeruginosa, S.areus, Klebsiel-la spp, Enterococcus spp, Enterobacter spp, Acinetobacter spp were the main microorganisms.Oxacillin resistant strains accounted for 22.0% and 69.9% of S.aureus and CNS respectively; In Enterococcus spp.vancomycin resistant strains accounted for 3.1% and 1.9% of E.fecalis and E.fecium, respectively.Imipenem ceftazidime, amikacin, ciprofloxacin, piperacillin and cefotaxime were the most active agents against Gram - negative organisms including Enterobacteriaceae and glucose nonfermenters, while the susceptible rates were significantly lower as compared with the data in 1996 and 1999.Condutions The results suggested that it is an urgent need for surveillance of bacteria resistance in different districts and rational use of antimicrobial agents should be emphasized during clinical therapy.
出处 《中国预防医学杂志》 CAS 2001年第3期185-187,共3页 Chinese Preventive Medicine
关键词 微生物 细菌 药物监测 耐药性 药物敏感性 Drug resistance Microbial Bacteria Drug monitoring
  • 相关文献

参考文献5

二级参考文献20

  • 1汪复.抗菌药物临床应用进展[J].中华传染病杂志,1996,14(1):36-40. 被引量:22
  • 2汪复,朱德妹,张婴元.上海部分医院细菌耐药性监测及其临床意义[J].中华传染病杂志,1996,14(3):148-151. 被引量:101
  • 3湖北地区细菌耐药性监测协作组.湖北地区临床常见菌群与耐药性监测[J].实用医学检验杂志,2000,7:7-7.
  • 4汪复,中华传染病杂志,1996年,14卷,148页
  • 5王辉,中华微生物学和免疫学杂志,1995年,15卷,430页
  • 6周贵民,中华微生物学和免疫学杂志,1995年,15卷,219页
  • 7朱德妹,中国抗生素杂志,1994年,13卷,142页
  • 8张群智,中华医学检验杂志,1998年,21卷,73页
  • 9马俊春,中华医学检验杂志,1995年,18卷,164页
  • 10Ho P L,Antimicrobial Agents Chemother,1999年,43卷,1310页

共引文献399

同被引文献41

  • 1申正义,孙自镛,王洪波.湖北地区临床分离菌耐药性监测[J].中国抗感染化疗杂志,2004,4(5):263-267. 被引量:36
  • 2汪复.2005中国CHINET细菌耐药性监测结果[J].中国感染与化疗杂志,2006,6(5):289-295. 被引量:284
  • 3Clinical and Laboratory Standards Institute (CLSI/NCCI.S). Performance Standards for Antirnicrobial Susceptibility Tes ting: Fifteenth Informational Supplement [S]. 2008 ,M100- S18.
  • 4[1]National Committee for Clinical Laboratory Standard. Performance standards for antimicrobial susceptibility testing. ninth informational supplement [S]. M100-S9 Vol 19. Pennsylvania:NCCLS, NO1, January 1999
  • 5[7]World Health Organization. WHO Prevention of hospital-acquired infections. WHO/CDS/CSR/EPH/2002,12
  • 6[9]World Health Organization. WHO Global strategy for containment of antimicrobial resistance. WHO/CDS/CSR/DRS/2001,2
  • 7World Health Organization.WHO global strategy for containment of antimicrobial resistance[EB/ OL].WHO/ CDS/ CSR/DRS/ 2001.2.
  • 8Clinical and Laboratory Standards Institute (CLSI/NCCLS).Performance Standards for Antimicrobial Susceptibility Testing;Fifteenth Informational Supplement[S].2009,M100-S19.
  • 9Paterson DL.The epidemiological profile of infections with multidrug-resistant Pseudomonas aeruginosa and Acinetobacter species[J].Clin Infect Dis,2006,43 (Suppl 2):S43-S48.
  • 10Reygaert W.Methicillin-resistant Staphylococcus aureus (MRSA):prevalence and epidemiology issues[J].Clin Lab Sci,2009,22(2):111-114.

引证文献6

二级引证文献91

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部